Standout Papers

The diagnosis of mild cognitive impairment due to Alzheimer's dis... 2004 2026 2011 2018 7.0k
  1. The diagnosis of mild cognitive impairment due to Alzheimer's disease: Recommendations from the National Institute on Aging‐Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease (2011)
    Marilyn S. Albert, Steven T. DeKosky et al. Alzheimer s & Dementia
  2. Mild cognitive impairment as a diagnostic entity (2004)
    Ronald C. Petersen Journal of Internal Medicine
  3. Hypothetical model of dynamic biomarkers of the Alzheimer's pathological cascade (2009)
    Clifford R. Jack, David S. Knopman et al. The Lancet Neurology
  4. Tracking pathophysiological processes in Alzheimer's disease: an updated hypothetical model of dynamic biomarkers (2013)
    Clifford R. Jack, David S. Knopman et al. The Lancet Neurology
  5. The Diagnosis of Mild Cognitive Impairment due to Alzheimer’s Disease: Recommendations from the National Institute on Aging-Alzheimer’s Association Workgroups on Diagnostic Guidelines for Alzheimer’s Disease (2013)
    Marilyn S. Albert, Steven T. DeKosky et al. FOCUS The Journal of Lifelong Learning in Psychiatry
  6. Diagnostic criteria for mild cognitive impairment in Parkinson's disease: Movement Disorder Society Task Force guidelines (2012)
    Irene Litvan, Jennifer G. Goldman et al. Movement Disorders
  7. Cerebrospinal fluid biomarker signature in Alzheimer's disease neuroimaging initiative subjects (2009)
    Leslie M. Shaw, Hugo Vanderstichele et al. Annals of Neurology
  8. Practice parameter: Early detection of dementia: Mild cognitive impairment (an evidence-based review) [RETIRED] (2001)
    Ronald C. Petersen, J E Stevens et al. Neurology
  9. Alzheimer's Disease Neuroimaging Initiative (ADNI) (2009)
    Ronald C. Petersen, Paul Aisen et al. Neurology
  10. Practice guideline update summary: Mild cognitive impairment [RETIRED] (2017)
    Ronald C. Petersen, Oscar L. López et al. Neurology
  11. Alzheimer disease (2021)
    David S. Knopman, Hélène Amieva et al. Nature Reviews Disease Primers
  12. Neuronal loss correlates with but exceeds neurofibrillary tangles in Alzheimer's disease (1997)
    Teresa Gómez‐Isla, Richard Hollister et al. Annals of Neurology
  13. A/T/N: An unbiased descriptive classification scheme for Alzheimer disease biomarkers (2016)
    Clifford R. Jack, David A. Bennett et al. Neurology
  14. Mild Cognitive Impairment (2009)
    Ronald C. Petersen, Rosebud O. Roberts et al. Archives of Neurology
  15. The Alzheimer's Disease Neuroimaging Initiative (2005)
    Susanne G. Mueller, Michael W. Weiner et al. Neuroimaging Clinics of North America
  16. Mild Cognitive Impairment (2011)
    Ronald C. Petersen New England Journal of Medicine
  17. Medial temporal atrophy on MRI in normal aging and very mild Alzheimer's disease (1997)
    Clifford R. Jack, Ronald C. Petersen et al. Neurology
  18. Serial PIB and MRI in normal, mild cognitive impairment and Alzheimer's disease: implications for sequence of pathological events in Alzheimer's disease (2009)
    Clifford R. Jack, Val J. Lowe et al. Brain
  19. Ways toward an early diagnosis in Alzheimer's disease: The Alzheimer's Disease Neuroimaging Initiative (ADNI) (2005)
    Susanne G. Mueller, Michael W. Weiner et al. Alzheimer s & Dementia
  20. 11C PiB and structural MRI provide complementary information in imaging of Alzheimer's disease and amnestic mild cognitive impairment (2008)
    Clifford R. Jack, Val J. Lowe et al. Brain
  21. Increased Risk of Type 2 Diabetes in Alzheimer Disease (2004)
    Juliette Janson, Joseph E. Parisi et al. Diabetes
  22. Identification of preclinical Alzheimer's disease by a profile of pathogenic proteins in neurally derived blood exosomes: A case‐control study (2014)
    Massimo S. Fiandaca, Dimitrios Kapogiannis et al. Alzheimer s & Dementia
  23. Mild Cognitive Impairment as a Clinical Entity and Treatment Target (2005)
    Ronald C. Petersen, John C. Morris Archives of Neurology
  24. Rates of hippocampal atrophy correlate with change in clinical status in aging and AD (2000)
    Clifford R. Jack, Ronald C. Petersen et al. Neurology
  25. The Alzheimer's Disease Neuroimaging Initiative: A review of papers published since its inception (2013)
    Michael W. Weiner, Dallas P. Veitch et al. Alzheimer s & Dementia
  26. Aging, Memory, and Mild Cognitive Impairment (1997)
    Ronald C. Petersen, Glenn E. Smith et al. International Psychogeriatrics
  27. MR‐based hippocampal volumetry in the diagnosis of Alzheimer's disease (1992)
    Clifford R. Jack, Ronald C. Petersen et al. Neurology
  28. Neuropathologically defined subtypes of Alzheimer's disease with distinct clinical characteristics: a retrospective study (2011)
    Melissa E. Murray, Neill R. Graff‐Radford et al. The Lancet Neurology
  29. Classifying neurocognitive disorders: the DSM-5 approach (2014)
    Perminder S. Sachdev, Deborah Blacker et al. Nature Reviews Neurology
  30. Comparison of different MRI brain atrophy rate measures with clinical disease progression in AD (2004)
    Clifford R. Jack, Maria M. Shiung et al. Neurology
  31. The Mayo Clinic Study of Aging: Design and Sampling, Participation, Baseline Measures and Sample Characteristics (2008)
    Rosebud O. Roberts, Yonas E. Geda et al. Neuroepidemiology
  32. Physical Exercise as a Preventive or Disease-Modifying Treatment of Dementia and Brain Aging (2011)
    J. Eric Ahlskog, Yonas E. Geda et al. Mayo Clinic Proceedings
  33. Defining imaging biomarker cut points for brain aging and Alzheimer's disease (2016)
    Clifford R. Jack, Heather J. Wiste et al. Alzheimer s & Dementia
  34. Prevalence of mild cognitive impairment is higher in men (2010)
    Ronald C. Petersen, Rosebud O. Roberts et al. Neurology
  35. Normative spatiotemporal gait parameters in older adults (2011)
    John H. Hollman, Eric McDade et al. Gait & Posture
  36. Amyloid deposition, hypometabolism, and longitudinal cognitive decline (2012)
    Susan Landau, Mark A. Mintun et al. Annals of Neurology
  37. Detecting Dementia With the Mini-Mental State Examination in Highly Educated Individuals (2008)
    Sid E. O’Bryant, Joy D. Humphreys et al. Archives of Neurology
  38. Mild Cognitive Impairment (2016)
    Ronald C. Petersen CONTINUUM Lifelong Learning in Neurology
  39. Association of Mediterranean Diet with Mild Cognitive Impairment and Alzheimer's Disease: A Systematic Review and Meta-Analysis (2014)
    Balwinder Singh, Ajay K. Parsaik et al. Journal of Alzheimer s Disease
  40. Plasma phospho‐tau181 increases with Alzheimer's disease clinical severity and is associated with tau‐ and amyloid‐positron emission tomography (2018)
    Michelle M. Mielke, Clinton E. Hagen et al. Alzheimer s & Dementia
  41. Cascading network failure across the Alzheimer’s disease spectrum (2015)
    David T. Jones, David S. Knopman et al. Brain
  42. Cellular senescence in brain aging and neurodegenerative diseases: evidence and perspectives (2018)
    Darren J. Baker, Ronald C. Petersen Journal of Clinical Investigation
  43. An autoradiographic evaluation of AV-1451 Tau PET in dementia (2016)
    Val J. Lowe, Geoffry L. Curran et al. Acta Neuropathologica Communications
  44. Understanding disease progression and improving Alzheimer's disease clinical trials: Recent highlights from the Alzheimer's Disease Neuroimaging Initiative (2018)
    Dallas P. Veitch, Michael W. Weiner et al. Alzheimer s & Dementia
  45. Longitudinal tau PET in ageing and Alzheimer’s disease (2018)
    Clifford R. Jack, Heather J. Wiste et al. Brain
  46. Performance of plasma phosphorylated tau 181 and 217 in the community (2022)
    Michelle M. Mielke, Jeffrey L. Dage et al. Nature Medicine
  47. Comparison of Plasma Phosphorylated Tau Species With Amyloid and Tau Positron Emission Tomography, Neurodegeneration, Vascular Pathology, and Cognitive Outcomes (2021)
    Michelle M. Mielke, Ryan D. Frank et al. JAMA Neurology
  48. Senolytic therapy in mild Alzheimer’s disease: a phase 1 feasibility trial (2023)
    Mitzi M. Gonzales, Valentina R. Garbarino et al. Nature Medicine
  49. Eligibility for Anti-Amyloid Treatment in a Population-Based Study of Cognitive Aging (2023)
    Jeremiah A. Aakre, Vijay K. Ramanan et al. Neurology

Immediate Impact

6 by Nobel laureates 25 from Science/Nature 279 standout
Sub-graph 1 of 12

Citing Papers

From geroscience to precision geromedicine: Understanding and managing aging
2025 Standout
Biomarker Changes during 20 Years Preceding Alzheimer’s Disease
2024 Standout
149 intermediate papers

Works of Ronald C. Petersen being referenced

Tracking pathophysiological processes in Alzheimer's disease: an updated hypothetical model of dynamic biomarkers
2013 Standout
Hypothetical model of dynamic biomarkers of the Alzheimer's pathological cascade
2009 Standout
and 138 more

Author Peers

Author Last Decade Papers Cites
Ronald C. Petersen 59507 50178 16818 28644 1.1k 112.7k
David S. Knopman 46210 39897 13847 22491 986 90.7k
John C. Morris 46867 43206 9339 24123 986 112.4k
Clifford R. Jack 52132 44990 13321 29145 1.1k 101.3k
Philip Scheltens 42680 35634 12704 29096 1.2k 97.2k
Jeffrey L. Cummings 43937 30007 15317 21266 946 99.9k
Bruce L. Miller 31246 28417 24931 28222 1.1k 87.9k
Michael W. Weiner 29962 27237 8059 19528 876 69.0k
Bradley T. Hyman 23741 59624 14577 18038 723 111.3k
Kaj Blennow 40289 64391 23752 10218 2.0k 118.7k
Steven T. DeKosky 28721 24817 9440 11523 539 62.2k

All Works

Loading papers...

Rankless by CCL
2026